Shameek Konar - Dec 29, 2023 Form 4 Insider Report for Comera Life Sciences Holdings, Inc. (CMRA)

Role
Member of 10% owner group
Signature
/s/ Shameek Konar
Stock symbol
CMRA
Transactions as of
Dec 29, 2023
Transactions value $
$112,500
Form type
4
Date filed
2/2/2024, 07:48 PM
Previous filing
Feb 2, 2024
Next filing
May 28, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CMRA 12.0% Senior Secured Convertible Notes Purchase $113K $113K Dec 29, 2023 Common Stock 2.05M $0.06 By Regolith Capital Investments L.P. F1, F2
transaction CMRA Warrants to Purchase Common Stock Purchase $0 +4.09M $0.00 4.09M Dec 29, 2023 Common Stock 4.09M $0.06 By Regolith Capital Investments L.P. F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Regolith Capital Investments, L.P. ("Regolith") entered into a Securities Purchase Agreement with the Issuer on December 29, 2023, pursuant to which Regolith acquired (i) $112,500 principal amount of the Issuer's 12.0% Senior Secured Convertible Notes (the "Notes") and (ii) 4,090,908 warrants, each exercisable to purchase one share of the Company's common stock, par value $0.0001 per share ("Common Stock"), at an exercise price of $0.055 per share (the "Warrants"), representing 200% of the number of shares of Common Stock issuable upon conversion of the Notes immediately after the issuance thereof.
F2 The reporting persons are general partners of Regolith and disclaim beneficial ownership of the securities held by Regolith except to the extent of their pecuniary interest therein